Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir. - Wikidata - wikimedia - TriplyDB

Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir.

Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir.

http://www.wikidata.org/entity/Q37613237

about

Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy.Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls.Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

P2860

Q40103229-615EE3EA-7EF6-4B8E-87D6-9EDF5B4AB3A8 Q41932859-4D3D72F9-7B32-4919-B568-F36EE92E3D11 Q48507049-389EE9C3-3FD4-474B-B965-13782E3418CA

P2860

Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir.

http://www.wikidata.org/entity/Q37613237

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Improved kidney function in pa ...... vir or lopinavir to darunavir.

@en

Improved kidney function in pa ...... vir or lopinavir to darunavir.

@nl

type

label

Improved kidney function in pa ...... vir or lopinavir to darunavir.

@en

Improved kidney function in pa ...... vir or lopinavir to darunavir.

@nl

prefLabel

Improved kidney function in pa ...... vir or lopinavir to darunavir.

@en

Improved kidney function in pa ...... vir or lopinavir to darunavir.

@nl

P1433

Q37613237-F7D0F99E-6EBF-4E77-82A7-2FA7CABA47E6

P1476

Q37613237-8A0441E3-C901-4846-BD81-91540C8B5080

P2093

Q37613237-26E5E14E-D2A1-42FB-B13F-0CAEB708A9E9

Q37613237-42356C29-F295-48E7-9CD6-66278299EB23

Q37613237-4CCB3662-8F1C-4834-B92E-7379DE3A8ADA

Q37613237-4CCF4949-AE85-4BC9-AD8C-05FA2782D442

Q37613237-5BDFA3A4-73E4-42A5-B228-FB78DBDD1436

Q37613237-88450FF1-9109-4AEC-9417-CEC6EE28B170

Q37613237-894A9E31-73FB-4F42-808A-D820BC1C8436

Q37613237-A935E1D3-B54C-4BD4-A7E1-9ED69656308E

Q37613237-C72D68EB-09F3-4694-984F-A420BB3934A2

Q37613237-CA68B4AA-058D-4CB2-9118-51BB192AC2D8

P2860

Q37613237-01A37A0D-9468-4972-AB96-B5E50A6D4CC3

Q37613237-181E11F4-991D-4366-949D-7B4AB279A215

Q37613237-22A27916-149C-4115-86B4-C17A1CBFB1BE

Q37613237-2CC52542-3E13-4D87-B8B5-57A29A8E97FB

Q37613237-395AD28D-A835-4C3D-8604-09C224B0F714

Q37613237-575AB851-DEA7-4674-B549-04FD7D047FFF

Q37613237-5B4056B8-8E87-42F9-A478-7552C4E47E35

Q37613237-64F1A854-8B84-4779-8C25-C5943E2CDC33

Q37613237-6CBE12AD-A028-492E-B00C-77718BC7BD41

Q37613237-70F95873-CC92-4898-AAD8-654A10EBBFA1

P304

Q37613237-CEBC3279-F08D-43F5-8D75-19C592969993

P31

Q37613237-8B68BBD0-FFE1-4112-999D-A5577C45281A

P356

Q37613237-BFED6D47-32FE-4D90-BB69-8E809606987F

P407

Q37613237-DC264C20-B380-4B21-9CA7-C70A51F1B0CE

P433

Q37613237-2C1E2D73-D0B7-4DC2-89F9-6B5487B9D032

P478

Q37613237-FE6C74C6-F9BE-4F8A-9536-7EA6A30BDF3B

P50

Q37613237-E1E35FD5-B1B6-4D0F-85C2-76E96711F1F0

P577

Q37613237-4ADB5427-49DA-4F1F-BB8B-96539CFDE0D1

P698

Q37613237-9C9F5ACA-A727-480B-95F5-B9EE328C2DB5

P932

Q37613237-7264F9BE-290B-44DF-A295-B3AB54E7B115

P356

QAD.0000000000001353

P1433

P1476

Improved kidney function in pa ...... vir or lopinavir to darunavir.

@en

P2093

Andrew Phillips

http://www.w3.org/2001/XMLSchema#string

David Chadwick

http://www.w3.org/2001/XMLSchema#string

Deborah I Williams

http://www.w3.org/2001/XMLSchema#string

Frank A Post

http://www.w3.org/2001/XMLSchema#string

Lisa Hamzah

http://www.w3.org/2001/XMLSchema#string

Mark Nelson

http://www.w3.org/2001/XMLSchema#string

Rachael Jones

http://www.w3.org/2001/XMLSchema#string

Roy Trevelion

http://www.w3.org/2001/XMLSchema#string

Sophie Jose

http://www.w3.org/2001/XMLSchema#string

UK CHIC study

http://www.w3.org/2001/XMLSchema#string

P2860

Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposure

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.

Ritonavir-boosted darunavir is rarely associated with nephrolithiasis compared with ritonavir-boosted atazanavir in HIV-infected patients

Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study

Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.

Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.

Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks.

Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment: 48-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study

Ritonavir-induced acute kidney injury: kidney biopsy findings and review of literature.

Association of tenofovir exposure with kidney disease risk in HIV infection.

P304

485-492

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0000000000001353

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28121667

http://www.w3.org/2001/XMLSchema#string

P932

5278893

http://www.w3.org/2001/XMLSchema#string